SCHEMBL8387112

SCHEMBL8387112

C=CCOC(=O)Cc1ccc2cc[nH]c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 3/20 0.45
▸ ENPP2 Q13822 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2A6 P11509 1/20 0.39
▸ MAOA P21397 1/20 0.39
▸ TYR P14679 1/20 0.38
▸ BACE1 P56817 3/20 0.38
▸ CACNA1H O95180 2/20 0.38
▸ YWHAG P61981 1/20 0.38
▸ CACNA1G O43497 1/20 0.38
▸ CACNA1I Q9P0X4 1/20 0.38
▸ FAAH O00519 1/20 0.37
▸ TUBB4A P04350 1/20 0.37
▸ TUBB P07437 1/20 0.37
▸ TUBA3C P0DPH7 1/20 0.37
▸ TUBA1B P68363 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10420380 0.82 NLRP3 (0.52) NLRP3ENPP2KDM4EALDH1A1HPGD
SCHEMBL30054080 0.82 NLRP3 (0.52) NLRP3ENPP2KDM4EALDH1A1HPGD
SCHEMBL17457016 0.81 ALDH1A1 (0.54) ENPP2KDM4EALDH1A1HPGDHSD17B10
SCHEMBL11976503 0.79 NLRP3 (0.53) NLRP3ENPP2KDM4EALDH1A1HPGD
SCHEMBL17386357 0.77 CYP3A4 (0.50) ALDH1A1HSD17B10CYP3A4
SCHEMBL11775208 0.76 ALDH1A1 (0.39) KDM4EALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL12481099 0.75 NLRP3 (0.48) NLRP3ENPP2KDM4EALDH1A1HPGD
SCHEMBL29627552 0.75 KDM4E (0.56) NLRP3ENPP2KDM4EALDH1A1HPGD
SCHEMBL3105331 0.75 KDM4E (0.56) NLRP3ENPP2KDM4EALDH1A1HPGD
SCHEMBL8802614 0.74 ENPP2 (0.39) ENPP2KDM4EALDH1A1HSD17B10CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877199-A ALZHEIMER'S DISEASE; SEDATIVE SANKYO COMPANY, LIMITED (JP) 1999-03-02 — — US disclosed
CN-1166169-A Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors SANKYO CO (JP) 1997-11-26 — — CN disclosed
EP-0804416-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY LIMITED (JP) 1997-11-05 — — EP disclosed
WO-1996003377-A1 HETEROCYCLIC COMPOUNDS, USEFUL AS ALLOSTERIC EFFECTORS AT MUSCARINIC RECEPTORS SANKYO COMPANY, LIMITED (JP) 1996-02-08 — — WO disclosed
Send feedback